Jeffrey Bird

Jeffrey Bird, M.D., Ph.D., is a managing director at Sutter Hill Ventures, where he focuses on healthcare, including biotechnology and genomic technologies. Dr. Bird has been a board member of several public and private biotechnology companies over a 17-year investing career. Dr. Bird was previously senior vice president, business operations at Gilead Sciences Inc., where he worked for about 10 years and oversaw Gilead’s commercial sales and marketing teams, corporate development, and other functions. He received his B.S., M.D., and a Ph.D. in cancer biology from Stanford University.